Skip to content
Stay curious ↗

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

Today/Digital Health
Digital Health · The big question

White House Partners With Amazon and Mark Cuban to Expand TrumpRx

STAT+: White House taps Amazon, GoodRx, and Mark Cuban to bolster TrumpRx

STAT News1 min readAI-assisted summary
Editorial illustration for STAT+: White House taps Amazon, GoodRx, and Mark Cuban to bolster TrumpRx
Editorial illustration

Summary

The White House is expanding its prescription drug discount website, TrumpRx, by adding more than 600 generic medications to its catalog. Generic drugs are affordable copies of brand-name medications that have the same active ingredients and clinical effects. This expansion aims to simplify the process of shopping for affordable healthcare by giving consumers a centralized place to search for the best prices.

To build this massive catalog, the government is teaming up with major players in the healthcare savings space. The updated platform relies on new partnerships with Amazon Pharmacy, GoodRx, and entrepreneur Mark Cuban's Cost Plus Drug Company. Instead of checking multiple websites to find a good deal, patients can now use the single government platform to locate the lowest possible cost for their generic prescriptions.

Why it matters.

Navigating prescription drug costs in the United States is notoriously complicated. While private companies have created innovative ways to offer cheap generics, patients often have to hunt across different apps and websites to find the best deal. A centralized platform could streamline this process, potentially saving patients both time and money when filling their daily prescriptions.

However, it is important to note that this project is still in its early stages. Because this information comes from an initial press announcement, there is no hard data yet on actual out-of-pocket consumer savings. We will need to monitor platform utilization metrics and long-term market data to see if this partnership truly changes how Americans buy their medicine.

From the source

The story in numbers.

Generic drugs added to the platform
600+
Major corporate partners announced
3
Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Your next discovery.

Keep exploring ↗
Digital Health

Upgraded medical AI can now request and analyze diverse diagnostic data.

Imagine chatting with a computer program that not only understands your symptoms but can also act like a medical detective. Researchers have developed a specialized artificial intelligence called the Articulate Medical Intelligence Explorer, or AMIE. This system is a large language model, which is a type of AI trained on vast amounts of text to understand and generate human language. Unlike general conversational programs, AMIE is custom-built specifically to hold diagnostic conversations with patients. Recent upgrades have given AMIE a powerful new set of skills. The AI can now handle multimodal medical data, meaning it can process different kinds of information at the same time. Instead of just passively receiving a list of symptoms, the upgraded system can actively ask for specific medical data, interpret those results, and use that combined information to logically think through a potential diagnosis.

Nature Medicine1 min read
Digital Health

New AI Tool Uses Retinal Scans to Detect Multiple Diseases

Researchers have developed a new artificial intelligence system designed to detect multiple diseases just by analyzing images of the eye. Known as Reti-Pioneer, this computer program examines scans of the retina, the light-sensitive tissue at the back of the eye. By reviewing these pictures, the AI can check for signs of several different health conditions all at once. To build this tool, the research team trained the AI using a massive collection of eye images gathered from various healthcare centers, ranging from local community clinics to large, specialized hospitals. This broad mix of data helps ensure the program works well for different types of patients. The creators then tested the system using outside data, confirming that it performs reliably beyond the original images it was trained on. The system has already been put to the test in real healthcare settings. Through an initial pilot study and a silent trial, where the AI ran in the background without affecting patient care, researchers showed that the tool is fast and practical for doctors to use. However, the study does not yet specify exactly which diseases the AI targets, the exact number of patients tested, or the precise accuracy rates of the diagnoses.

Nature Medicine1 min read
Digital Health

Supreme Court Preserves Telehealth Access to Mifepristone for Now

The Supreme Court has decided that mifepristone, a key medication used in medical abortions, can still be prescribed through telehealth and delivered by mail for the time being. This decision reverses a recent ruling by the 5th Circuit Court of Appeals, which had attempted to temporarily block doctors from prescribing the medication remotely. The legal dispute centers on safety protocols known as Risk Evaluation and Mitigation Strategies. Originally, these rules required patients to obtain mifepristone in person, but the Food and Drug Administration lifted those specific restrictions in 2021 to allow remote prescribing. The state of Louisiana is currently challenging this change in court, arguing that allowing doctors to prescribe the drug via telehealth directly undermines the state's strict abortion ban. It is important to note that the current Supreme Court decision is only a temporary measure. The broader case will continue to move its way through the justice system, meaning the ultimate legality of telehealth distribution for mifepristone remains highly uncertain.

STAT News1 min read

A little science goes a long way.

Clear, thoughtful biotech briefings. In your inbox three times a week.

Stay curious. Subscribe free ↗